Randomized phase III trial of avelumab + axitinib vs sunitinib as first-line treatment for advanced renal cell carcinoma: JAVELIN renal 101 Japanese subgroup analysis Meeting Abstract
| Authors: | Uemura, M.; Tomita, Y.; Miyake, H.; Hatakeyama, S.; Kanayama, H. O.; Numakura, K.; Takagi, T.; Kato, T.; Eto, M.; Obara, W.; Uemura, H.; Motzer, R. J.; Fujii, Y.; Kamei, Y.; Oya, M. |
| Abstract Title: | Randomized phase III trial of avelumab + axitinib vs sunitinib as first-line treatment for advanced renal cell carcinoma: JAVELIN renal 101 Japanese subgroup analysis |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz249.052 |
| Language: | English |
| ACCESSION: | WOS:000491295503005 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz249.052 |
| Notes: | Meeting Abstract: 956P -- Appears on pages v386-v387 of the abstract book -- Source: Wos |
